Navigation Links
New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
Date:4/28/2008

of an established battle management system that enables commanders and their staffs to collaboratively develop operational plans, then monitor plan rehearsal and execution from geographically dispersed headquarters.

General Dynamics C4 Systems, a business unit of General Dynamics (NYSE: GD), is a leading integrator of secure communication and information systems and technology.

General Dynamics, headquartered in Falls Church, Va., employs approximately 83,500 people worldwide and reported 2007 revenues of $27.2 billion. The company is a market leader in business aviation; land and expeditionary combat systems, armaments and munitions; shipbuilding and marine systems; and information systems and technologies. More information about the company is available on the Internet at http://www.generaldynamics.com.


'/>"/>
SOURCE General Dynamics C4 Systems
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
3. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
4. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
7. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
8. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
11. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... YORK, Dec. 16 Keryx Biopharmaceuticals, ... the initiation of a Phase 3 registration ... PI3K/Akt pathway inhibitor, in relapsed / refractory ... "A Phase 3 Randomized Study to Assess ... to the Combination of Bortezomib (Velcade®) and ...
(Date:12/16/2009)... -- , - ... a Total of Over,640 patients Ahead of ... NV (Euronext Brussels: THR), a biopharmaceutical company,focused ... treatments for eye,disease, vascular disease and cancer, ... of the second Phase III trial evaluating ...
(Date:12/15/2009)... Ga., Dec. 15 Immucor, Inc. (Nasdaq: ... systems to the blood transfusion industry, today announced that ... on Wednesday, January 6, 2010 after the market close. ... January 7, 2010 at 8:30 a.m. (Eastern Time) to ... to participate in this conference call by dialing 1-888-324-9321 ...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 63092 1Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 63092 2Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 63092 3Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration 28FDA 29 and Food Safety and Inspection 63090 1Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration 28FDA 29 and Food Safety and Inspection 63090 2Human Rights Denied 3A Obama Leaves 75 Million Children Behind 63088 1Human Rights Denied 3A Obama Leaves 75 Million Children Behind 63088 2
... 2007 /PRNewswire-FirstCall/ --,Phosphagenics Limited (AIM: PSG) announced ... Phase 1b clinical trial to demonstrate the,efficacy ... its transdermal,insulin product, TPM-02/Insulin, containing long-acting insulin.,The ... second quarter of,2007. , TPM-02/Insulin gel is ...
... ON, May 02, 2007 /PRNewswire-FirstCall/ - ... that identifies, develops,and commercializes differentiated products ... from its randomized,placebo-controlled Phase IIb trial ... post-operative pain following orthopedic surgery.,AeroLEF(TM) met ...
Other Medicine Technology:Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical,Trial in Second Quarter 2YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets,Primary Endpoint in Patients with Post-Surgical Pain 2YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets,Primary Endpoint in Patients with Post-Surgical Pain 3
(Date:12/16/2009)... Market Expansion , ... Ramat-Gan, Israel (PRWEB) December 16, ... Web sites and companies, today announced a record year of growth ... its launch on July 2008, Kampyle has processed more than 12 ... than 30,000 customers in 191 countries., , ,Kampyle pioneered the ...
(Date:12/16/2009)... SCHAFFHAUSEN, Switzerland, Dec. 16 Tyco International ... the nomination of Michael E. Daniels for election ... company,s Annual General Meeting on March 10, 2010. ... of the Global Technology Services group of International ... worldwide responsibility for IBM,s Global Services business operations ...
(Date:12/16/2009)... Medizone International, Inc. (OTC Bulletin Board: ... Directors and the Board of Medizone New Zealand ... Inc. holds a 50% interest, agreed on December ... reconvey to Medizone International all global marketing rights ... Chairman, Edwin G. Marshall said, "Time has eroded ...
(Date:12/16/2009)... the ,70s, study finds , , TUESDAY, Dec. 15 (HealthDay ... United States than it was more than 30 years ... compared National Health and Nutrition Examination Survey data from ... and from 8,339 black and white participants from 1999 ... old. , The prevalence of myopia increased from 25 ...
(Date:12/16/2009)... in triathalons and appeared on The Amazing Race ... to think of herself as part human, part machine. , ... 34-year-old triathlete likes to describe herself. When she,s not training ... school auditoriums or posing nude with her metal leg crossed ... latest ESPN Body Issue. , She is the ...
Breaking Medicine News(10 mins):Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 2Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 3Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 4Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 5Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2Health News:Amputee Athlete Tells Her Story 2Health News:Amputee Athlete Tells Her Story 3Health News:Amputee Athlete Tells Her Story 4
... Interviews Available with Top Children,s Miracle Network Health Experts, SALT LAKE CITY, Oct. ... doctors and experts from 170 ... questions about Methicillin-resistant Staphylococcus Aureus ... is resistant to antibiotics, ...
... the Committee to Reduce Infection as an advisory to prevent ... hands frequently. 2. Parents, tuck a small container of ... mature enough to use it properly. 3. Educators, install ... get a hall pass and leave the,classroom to clean their ...
... in this weeks issue of the Proceedings of the National ... damaging effects of ultraviolet (UV) radiation the most abundant ... an extract of broccoli sprouts. , The results in ... that the degree of skin redness (erythema) caused by UV ...
... 22 Dialysis Corporation,of America (Nasdaq: DCAI ... third,quarter 2007 earnings after the close of the ... of America owns and operates freestanding kidney,hemodialysis centers ... Carolina and Virginia, and provides in-hospital,dialysis services on ...
... Frost & Sullivan Recognizes Achievements in Creating New Possibilities for ... ... Waters Corporation,(NYSE: WAT ) today announced that it has been ... by Frost & Sullivan.,The Market Leadership award is in recognition of ...
... quarter of the world,s adults are obese, study finds , , ... men and 30 percent of women are now overweight, and ... obese, say researchers who looked at data from 63 countries. ... and women ages 18-80 (average age 48), living on five ...
Other Medicine News:Health News:Children's Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection 2Health News:Committee to Reduce Infection Deaths Releases 10 Lifesaving Steps to Protect Students from MRSA Infections 2Health News:Broccoli sprout-derived extract protects against ultraviolet radiation 2Health News:Dialysis Corporation of America Announces Third Quarter 2007 Earnings Release Date 2Health News:Waters Corporation Receives Market Leadership and Product Innovation Awards 2Health News:Waters Corporation Receives Market Leadership and Product Innovation Awards 3Health News:Overweight Now a Global Problem 2
... innovative & portable FireFly LED light offers ... With the new FireFly LED you'll get ... go whereever your practice demands. High center-beam ... on your procedures, while the rechargeable battery ...
Easy pull-on design for continuous chin compression and support feature our exclusive Non-Slip Dome™...
For face-lifts and submental liposuction...
Very compressive support for submental liposuction...
Medicine Products: